Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and famil… Read more
Alibaba Health Information Technology Limited - Asset Resilience Ratio
Alibaba Health Information Technology Limited (ALBBY) has an Asset Resilience Ratio of 19.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2007–2025)
This chart shows how Alibaba Health Information Technology Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Alibaba Health Information Technology Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $4.45 Billion | 19.14% |
| Total Liquid Assets | $4.45 Billion | 19.14% |
Asset Resilience Insights
- Good Liquidity Position: Alibaba Health Information Technology Limited maintains a healthy 19.14% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Alibaba Health Information Technology Limited Industry Peers by Asset Resilience Ratio
Compare Alibaba Health Information Technology Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462 |
Pharmaceutical Retailers | 0.00% |
|
Yunnan Hongxiang Yixintang
SHE:002727 |
Pharmaceutical Retailers | 4.83% |
|
Luyan Pharma Co Ltd
SHE:002788 |
Pharmaceutical Retailers | 0.00% |
|
Ji Yao Holding Group Co Ltd
SHE:300108 |
Pharmaceutical Retailers | -0.02% |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937 |
Pharmaceutical Retailers | 0.06% |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017 |
Pharmaceutical Retailers | 0.41% |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126 |
Pharmaceutical Retailers | 2.54% |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408 |
Pharmaceutical Retailers | 0.94% |
Annual Asset Resilience Ratio for Alibaba Health Information Technology Limited (2007–2025)
The table below shows the annual Asset Resilience Ratio data for Alibaba Health Information Technology Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 27.77% | $5.88 Billion | $21.18 Billion | -3.00pp |
| 2024-03-31 | 30.77% | $6.06 Billion | $19.71 Billion | +30.81pp |
| 2022-03-31 | -0.04% | $-7.26 Million | $19.20 Billion | -0.05pp |
| 2021-03-31 | 0.01% | $1.43 Million | $17.74 Billion | -5.11pp |
| 2020-03-31 | 5.11% | $402.49 Million | $7.87 Billion | -23.92pp |
| 2019-03-31 | 29.03% | $1.74 Billion | $5.98 Billion | +0.33pp |
| 2018-03-31 | 28.70% | $892.88 Million | $3.11 Billion | +27.53pp |
| 2017-03-31 | 1.17% | $19.62 Million | $1.68 Billion | +0.34pp |
| 2016-03-31 | 0.83% | $11.22 Million | $1.35 Billion | +0.01pp |
| 2015-03-31 | 0.82% | $11.57 Million | $1.41 Billion | -0.19pp |
| 2014-03-31 | 1.01% | $3.97 Million | $391.08 Million | -7.41pp |
| 2013-03-31 | 8.43% | $30.88 Million | $366.36 Million | +0.70pp |
| 2012-03-31 | 7.73% | $33.77 Million | $436.68 Million | -1.14pp |
| 2011-03-31 | 8.88% | $42.38 Million | $477.37 Million | +2.27pp |
| 2010-03-31 | 6.60% | $33.05 Million | $500.33 Million | +4.51pp |
| 2009-03-31 | 2.10% | $11.16 Million | $531.78 Million | -0.14pp |
| 2008-03-31 | 2.24% | $16.15 Million | $721.22 Million | +0.61pp |
| 2007-03-31 | 1.63% | $15.22 Million | $932.82 Million | -- |